TFF Pharmaceuticals, Inc. (TFFP)
NASDAQ: TFFP · Real-Time Price · USD
1.900
-0.070 (-3.55%)
At close: Nov 4, 2024, 4:00 PM
1.860
-0.040 (-2.11%)
After-hours: Nov 4, 2024, 4:41 PM EST
TFF Pharmaceuticals Employees
TFF Pharmaceuticals had 19 employees as of December 31, 2023. The number of employees increased by 4 or 26.67% compared to the previous year.
Employees
19
Change (1Y)
4
Growth (1Y)
26.67%
Revenue / Employee
$63,294
Profits / Employee
-$1,020,317
Market Cap
6.59M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Universe Pharmaceuticals INC | 225 |
Zhongchao | 142 |
Check-Cap | 85 |
Aptose Biosciences | 36 |
Organovo Holdings | 20 |
Moleculin Biotech | 18 |
NLS Pharmaceutics AG | 7 |
Adial Pharmaceuticals | 7 |
TFFP News
- 7 weeks ago - TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID - GlobeNewsWire
- 7 weeks ago - TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization - GlobeNewsWire
- 3 months ago - TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection - GlobeNewsWire
- 4 months ago - TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities - GlobeNewsWire
- 5 months ago - TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing - GlobeNewsWire
- 6 months ago - TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing - GlobeNewsWire
- 6 months ago - TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection - GlobeNewsWire
- 6 months ago - TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update - GlobeNewsWire